Vertex Pharmaceuticals (VRTX) stock gets an upgrade from Canaccord Genuity after its Q4 2024 results on Tuesday, Read more here.

Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...

A team of geologists and mineral physicists at Harvard University, the University of California, Argonne National Laboratory ...

“London is encountering a gold shortage as many major gold holders are transferring their gold to the U.S. London companies ...

For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...

One of the most significant news items involving Vertex isn't reflected in the company's numbers just yet. Vertex's non-opioid pain relief drug, Journavx, received FDA approval on Jan. 30. The drug is ...

In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with ...

Egg prices are continuing to soar, causing some businesses to adjust their prices while others are eating the cost.

Update: The second wave on Wednesday is expected to be more substantial. Northern regions could see 5-7 inches. Metro St.

The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Clay Northam Wealth Management LLC increased its stake in Exxon Mobil Co. (NYSE:XOM – Free Report) by 8.4% in the fourth ...

Google just dropped 4 new Gemini 2.0-series models, with some designed for coding performance and complex prompts and the ...